Inverness Medical Innovations, Inc. 

(Public, NYSE:IMA)   Watch this stock   
Find more results for IMA
Feb 9, 2010
UBS Global Healthcare Services Conference
Nov 17, 2009
Lazard Capital Healthcare Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 3.37% -1.37%
Operating margin 10.07% 3.43%
EBITD margin - 19.33%
Return on average assets 1.08% -0.42%
Return on average equity 2.11% -1.38%
Employees 8,300 -

Address

51 Sawyer Road Suite 200
Waltham, MA 02453
United States - Map
+1-781-6473900 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Inverness Medical Innovations, Inc. discussed on blogs

RxNews Recap for Wednesday 02-03-10. Auxilium (AUXL) and ... - Mary Davila - BioMedReports.Com - Feb 3, 2010

Inverness Medical Innovations, Inc. discussions

  View all discussions »

Description

Inverness Medical Innovations, Inc. is a global developer, manufacturer and marketer of advanced consumer and professional medical diagnostic products. The Company is a supplier of consumer pregnancy and fertility/ovulation tests and rapid point-of-care diagnostics. The Company’s products and services are focused in the areas of infectious disease, cardiology, oncology, drugs of abuse and women’s health. In addition, it manufactures and markets a variety of vitamins and nutritional supplements. Inverness Medical Innovations, Inc. operates in four segments: professional diagnostic products, health management, consumer diagnostic, and vitamins and nutritional supplements.

Officers and directors

Ron Zwanziger
Chairman of the Board, President, Chief Executive Officer
Age: 55
Bio & Compensation - Reuters
David Teitel
Chief Financial Officer
Age: 45
Bio & Compensation - Reuters
David Toohey
President, Europe/Middle East
Age: 52
Bio & Compensation - Reuters
John Yonkin
President, Inverness Medical Innovations North America and President - Nutritionals
Age: 49
Bio & Compensation - Reuters
Ron Geraty M.D.
Chief Executive Officer of Alere Medical, Inc.
Age: 62
Bio & Compensation - Reuters
Paul T. Hempel
Senior Vice President - Leadership Development, Secretary and Special Counsel
Age: 60
Bio & Compensation - Reuters
Jon Russell
Vice President - Finance
Age: 44
Bio & Compensation - Reuters
Hilde Eylenbosch M.D.
Vice President of Marketing
Age: 45
Bio & Compensation - Reuters
Michael K. Bresson
Vice President - Mergers & Acquisitions
Age: 51
Bio & Compensation - Reuters
Emanuel Hart
Vice President - International Business, LAmARCIS
Age: 59
Bio & Compensation - Reuters